Valisure’s CEO, David Light, participated in Yale University’s Digital Medicine Symposium in May 2019 to discuss Digital Medicine and the Drug Supply Chain.

Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explored the current state and future potential of digital health. Speakers that joined David Light included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEOs from digital health companies, and academia.

‍

Valisure’s CEO, David Light, participated in Yale University’s Digital Medicine Symposium in May 2019 to discuss Digital Medicine and the Drug Supply Chain.

Digital Medicine attracted over $8 Billion in venture capital in 2018 with promises of “driving down costs and empowering consumers to take charge of their health”. The Yale Digital Medicine Symposium explored the current state and future potential of digital health. Speakers that joined David Light included entrepreneurs and national experts on artificial intelligence, health data outcomes, CEOs from digital health companies, and academia.

‍